EFTA02435719.pdf
PDF Source (No Download)
Extracted Text (OCR)
To:
Jeffrey Epsteirteevacation@gmail.com]
From:
Sent
Tue 11/10/2009 5:02:09 PM
Subject: Fw: GO3 next step partnership
FYI
This email and any files transmitted with it are confidential and intended solely for the use of the
individual or entity to whom they arc addressed. If you have received this email in error please
notify the sender
immediately.
From: "Tsai, Jennifer"
Date: Mon, 9 Nov 2009 14:44:04 -0500
To: Tove Skarsheim
Cc: Geir Frantzen
Samson, Imel
; Fuster,
Valentin
Subject: RE: GO3 next step partnership
Dear Ms. Skarsheim,
Please allow me to clarify. Dr. Fuster did receive you email and is currently traveling but he is
working on this. we would be happy to get back to you upon his return.
Thank you and have a great day.
Regards,
Jennifer W. Tsai
Assistant, Dr. Valentin Fuster
Director. Mount Sinai Heart
Tel:
Fax
From: Samson, Imelda
Sent: Monday, November 09, 2009 2:25 PM
To: Tove Skarsheim'
Cc: Geir Frantzen;_; Tsai, Jennifer
Subject: RE: GO3 next step partnership
I had forwarded everything to Dr. Fuster and according to his academic administrative assistant Jennifer
Tsai, It is all being taken cared of.
If you need anything else — let me know.
EFTA_R1_01507897
EFTA02435719
Imelda
From: Tove Skarsheim [mailto:
Sent: Friday, November 06, 2009 6:48 AM
To: Samson, Imelda
Cc: Geir Frantzen;
Subject: G03 next step partnership
Dear Imelda,
Thank you so much for sending over the study yesterday. Very interesting work.
We arc very pleased that Dr. Fuster is interested in working with the Duchess of York and the
rest of the GO3 team on this project. I had the pleasure of meeting Dr. Fuster a while back, and
I know that he has had some good meetings and dialogue around the project with the Duchess
since then. We are looking very much forward to taking this to the next level. Please find some
thoughts around the partnership below as promised to Dr.Fuster in the last meeting.
We have been told by Geir Frantzen that Dr.Fuster and the team would be interested in doing a
piece of research on the GO3 products showing the benefits of Omega-3. We are very interested
in conducting such a project with a professional team, as this could be a fantastic opportunity to
get this important message out to as many people as possible through our excellent spokes people
and to build a strong brand for Omega-3.
I am not sure about how much detail that has been communicated around the actual research
project so far in the meetings with Dr. Fuster, the Duchess and Geir Frantzen. From our point of
view, the next step of this should be a discussion with the team to understand what kind of
research Dr. Fuster had in mind when suggesting this. We would also like to present the new
product formulation to Dr. Fuster, as the testing should be done on this specific product. The
product will be a highly concentrated Omega-3 oil with added D-vitamins. More detail on product
specification will come later as this is still in the development phase. We would see it as an
advantage for the project going forward that Dr. Fuster and his team can see the product in the
development phase as they might have feedback on the formulation.
GO3 is delighted about the opportunity to work with the very best within this field. We believe
that this project will bring a lot of benefits to the partners involved and will work on finding a
partnership model that will benefit all parties.
It is our understanding that Dr. Fuster wants to create funds for the important work and research
that is done through his organization. There are different ways of setting this up, but we would
EFTA_R1_01507898
EFTA02435720
like to discuss a model first where every purchase gives a contribution to building these funds.
This could be combined with a first time contribution that will work as a start up fee for the
research and to get the partnership going. The actual numbers on these elements and payment
terms will be discussed between Keith Frankel, Geir Frantzen and Dr. Fuster.
Furthermore, when the brand is profitable and running we can create special campaigns for the
fund to create attention around special projects. Having a percentage of every purchase being
donated to the fund will secure a income stream to the project over time and will also give the
opportunity for American consumers to feel involved in supporting an important cause.
To build the credibility of the brand we would in return like Dr. Fuster to be involved in the GO3
brand out to the consumers. We need to discuss how this can be done in a manner that will suit all
involved , but the elements we would like to discuss are:
Use of quotes from Dr. Fuster about the benefits of Omega-3 on the GO3 website
Use of references to the research on the web site
Use of quotes or interview with Dr. Fuster in the infomercial
Use of research reference on pack after research has been conducted.
Use of reference to Dr. Fuster in PR initiatives
I hope that this can create a platform for further discussions. Please don't hesitate to contact me
if you have any immediate questions.
Best regards,
Tove Skarsheim
Marketing Director GO3
This email is for the intended recipient only and is confidential. If this email has been
misdirected, please let the sender know and delete it. Any disclosure, copying,
distribution is prohibited.
Although we take great care to protect our network from computer viruses, we accept
no responsibility for mail-borne viruses and recommend that you scan the email and its
attachments. If you do find any virus please let us know so that we may take
appropriate action.
EFTA_R1_01507899
EFTA02435721
For the legal protection of our business any email sent or received by us may be
monitored or intercepted.
EFTA_R1_01507900
EFTA02435722
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Email Addresses
Document Details
| Filename | EFTA02435719.pdf |
| File Size | 330.1 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 5,843 characters |
| Indexed | 2026-02-12T16:59:11.818338 |